By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Hematology Association 

Westblaak 71

Rotterdam    3012 KE  The Netherlands
Phone: 31-10-404-56-21 Fax: 31-10-436-18-17


Company News
TG Therapeutics (TGTX) Recaps Data From Triple Combination Therapy Trials At The 22nd European Hematology Association Annual Congress 6/26/2017 11:15:47 AM
Onconova (ONTX) Presents Rigosertib Data At The 22nd Congress Of The European Hematology Association In Madrid 6/26/2017 8:01:08 AM
European Hematology Association: Multicenter Open-Label Phase 2 Study Of Ibrutinib In Chronic Graft Versus Host Disease (cGVHD) After Failure Of Corticosteroids 6/26/2017 7:36:44 AM
European Hematology Association: Bleeding Or Clotting In Elderly Patients With Cancer-Associated Venous Thromboembolism: Which Is Worse? 6/26/2017 7:35:00 AM
European Hematology Association: Global Trial Of The Efficacy And Safety Of CTL019 In Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: An Interim Analysis Of The JULIET Study 6/26/2017 7:33:00 AM
European Hematology Association: Early Metabolic Response Determination By FDG-PET Allows Substantial Reduction Of Chemotherapy And Its Toxicity In Patients With Advanced Stage Hodgkin Lymphoma: The GHSG HD18 Study 6/26/2017 7:31:17 AM
European Hematology Association: Clinical And Biologic Covariates Of Outcomes In ZUMA-1: A Pivotal Trial Of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) In Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL) 6/26/2017 7:29:36 AM
Ra Pharma (RARX) Presents Data On Oral Small Molecule Complement Inhibitors At The 22nd Congress Of European Hematology Association 6/26/2017 6:45:43 AM
AOP Orphan Pharmaceuticals AG And PharmaEssentiaAnnounce Latest Clinical Results For Ropeginterferon Alfa-2b In Polycythemia Vera From 3 Abstracts Presented At The 22nd Congress Of The European Hematology Association In Madrid 6/26/2017 6:41:14 AM
Verastem (VSTM) Reports Phase II Long-Term Follow-Up Data For Duvelisib In Patients With Double-Refractory Follicular Lymphoma And Small Lymphocytic Lymphoma At The 22nd Congress Of The European Hematology Association 6/26/2017 6:06:54 AM